
👨🏼⚕️Medical Doctor @SanRaffaeleMI 💉Anesthesia and Intensive Care @SRanesthesiaICU 🚑Emergency technician @crocerossa 🏊♂️ Surf Lifesaver
Milano, Lombardia
Joined September 2021
- Tweets298
- Following187
- Followers307
- Likes598
Matteo Aldo Bonizzoni, MD retweeted
Dear Ozgun @OzgunOasiller ,
You had a beautiful mind, and you were only 30 years old.
Last year, you spent weeks in our hospital as an ESAIC mentee from Ankara. In that short time, you left a mark on all of us. We miss you deeply.
Matteo Aldo Bonizzoni, MD retweeted
𝐒𝐞𝐫𝐢𝐨𝐮𝐬 𝐬𝐜𝐢𝐞𝐧𝐜𝐞. 𝐔𝐧𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐟𝐨𝐫𝐦𝐚𝐭.
The @ISICEM Critical Care Input — presented this time in a new way. Watch it now and enjoy.
Credits @DrFDamico
#ISICEMelearning @NEJM
Full article nejm.org/doi/full/10.1056/NE…
Matteo Aldo Bonizzoni, MD retweeted
Esmolol reduces low cardiac output syndrome @MRE_signavitae @giovannilandoni
signavitae.com/articles/10.2…
Matteo Aldo Bonizzoni, MD retweeted
Huge participation this morning at our Journal Club @SRAnesthesiaICU , focused on organ donation after 10 years of the eCPR program for refractory cardiac arrest.
👏 Thanks to @MarinaPieri5 and @MABonizzoni for the outstanding presentation and discussion!
Matteo Aldo Bonizzoni, MD retweeted
Replying to @MABonizzoni @SRAnesthesiaICU @giovannilandoni @PontilloD_ @LosiggioRosario @alessanro_pruna @MMarmiere @MarinaPieri5 @AjelloValentina @paternoster_g
How common is Acute Normovolemic Hemodilution (ANH) in cardiac surgery worldwide?
Our survey reveals that:
🩸 17.5% of patients receive ANH
signavitae.com/articles/10.2…
Matteo Aldo Bonizzoni, MD retweeted
ANH trial
Results: In patients undergoing elective cardiac surgery, acute normovolaemic haemodilution, compared with usual care, did not reduce the number of patients requiring blood transfusion during their hospital stay.
#CCR25 nej.md/3FxdMrW
Matteo Aldo Bonizzoni, MD retweeted
🚨 Just published in @CircAHA: Results from our #PRINCEtrial!
🆚 Remote ischemic preconditioning (RIPC) or sham-RIPC
👥 1,213 patients undergoing major non-cardiac surgery
🫀 No difference in myocardial injury rates
🔗 ahajournals.org/doi/10.1161/…
#CCR25 @CritCareReviews
Matteo Aldo Bonizzoni, MD retweeted
🩸Among adults undergoing cardiac surgery, ANH did not reduce the number of patients receiving allogeneic red-cell transfusion.
These are the findings of the #ANHtrial, our latest multicenter RCT, just presented at #CCR25 and published in @NEJM.
📎 nejm.org/doi/full/10.1056/NE…
Matteo Aldo Bonizzoni, MD retweeted
Presented at #CCR25:
In the ANH phase 3 trial involving adult patients undergoing elective cardiac surgery, acute normovolemic hemodilution did not reduce the number of patients receiving allogeneic red-cell transfusion. Full trial results: nej.md/3FxdMrW
@CritCareReviews
Matteo Aldo Bonizzoni, MD retweeted
🚨 Just out in @NEJM: Results from our #ANHtrial!
💉 Acute Normovolemic Hemodilution (ANH) vs standard care (with no ANH)
🫀 2,010 cardiac surgery patients
🩸 No difference in post-op RBC transfusion rates
🔗 nej.md/3FxdMrW
#CCR25 @CritCareReviews
Matteo Aldo Bonizzoni, MD retweeted
🚨 Just published our secondary subgroup analysis of the #PROtectionTrial! 🚨
💡 Does IV #AminoAcids infusion still offer #renal protection in cardiac surgery patients with prolonged #CPB?
📌 Full paper jcvaonline.com/article/S1053…
#AKI #CardiacSurgery #CriticalCare
Matteo Aldo Bonizzoni, MD retweeted
When science meets style🌞🧠
Dr. @DrFDamico presents his C.L.E.A.R. study in a beautiful location to an exceptional audience. 🇮🇹📚✨
#clearstudy #MonashUniversity #Prato
Matteo Aldo Bonizzoni, MD retweeted
1/
Two of our multicenter RCTs will be presented in Belfat @CritCareReviews 2025!
@giovannilandoni @SRAnesthesiaICU
🔥 The countdown is on…
CCR25 is almost here.
Belfast. Big trials. Brilliant people.
Free livestream if you can't make it, but nothing beats being in the room
criticalcarereviews.com/meet…
#CCR25 #CriticalCare #ICU #FOAMed
Matteo Aldo Bonizzoni, MD retweeted
Four days in Baveno, for the OSR Scientific Retreat 2025 Congress 💙
@SanRaffaeleMI @MyUniSR
@SRAnesthesiaICU
Matteo Aldo Bonizzoni, MD retweeted
🚨 Just published our secondary subgroup analysis of the #PROTectionTrial! 🚨
💡 Does IV #AminoAcids infusion provide #renal #PROTection in patients receiving #tMCS?
🔍 Discover the rationale and key findings ⬇️
📢 Don’t miss this thread! 🧵
1/7
🔗 academic.oup.com/ejcts/advan…
Matteo Aldo Bonizzoni, MD retweeted
Replying to @SRAnesthesiaICU
@SRAnesthesiaICU contributed with 10 papers to the @EACTAIC @EACTS @The_EBCP Guidelines on CPB for Adult Cardiac Surgery, including three mRCT published on @NEJM!
➡️levosimendan
➡️volatile anesthetics vs propofol
➡️aminoacids
➡️sedation monitoring
➡️GDT
➡️calcium for CPB wean
Matteo Aldo Bonizzoni, MD retweeted
Live now in the plenary session: our @md_monaco presenting a speech on the use of VA-ECMO in interventional cardiology – at Bologna, Emilia Romagna
Matteo Aldo Bonizzoni, MD retweeted
Protection trial published in @NEJM by @giovannilandoni
Now at #ITACTA25!
How, where, when, and why aminoacids work
@ITACTAtwits
Matteo Aldo Bonizzoni, MD retweeted
Primo congresso da presidente 💪🏻@paternoster_g



































